EUVIMEDScopri EUVIMED
Crossref

The efficacy and safety of glucagon-like-peptide-1 agonists in patients with familial partial lipodystrophy

Maria Cristina Foss-freitas, Salman Imam, Adam Neidert, Anabela DillGomes, David Tyler Broome, Oral, Elif

University of Michigan Library · 2024-02-01

DOI: 10.7302/25183 ↗

At a glance

Journal article in University of Michigan Library, published on 2024-02-01. Written by Maria Cristina Foss-freitas and 6 co-authors.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

OBJECTIVE Glucagon-like peptide 1 receptor agonists (GLP-1RA) are widely used for the management of diabetes mellitus (DM), but their efficacy in familial partial lipodystrophy (FPLD) is unknown. In this retrospective study, we evaluated the effect of GLP-1RA in patients with FPLD. RESEARCH DESIGN AND METHODS We analyzed data, reported with SDs, from 14 patients with FPLD (aged 58 ± 12 years; 76.47% female) and 14 patients with type 2 DM (aged 58 ± 13 years; 71% female) before and 6 months after starting GLP-1RA. RESULTS We observed reduction in weight (95 ± 23 to 91 ± 22 kg; P = 0.002), BMI (33 ± 6 to 31 ± 6 kg/m2; P = 0.001), HbA1c (8.2% ± 1.4% to 7.7% ± 1.4%; P = 0.02), and fasting glucose (186 ± 64 to 166 ± 53 mg/dL; P = 0.04) in patients with FPLD. The change in triglycerides after treatment was greater in the FPLD group compared with the DM group (P = 0.02). We noted acute pancreatitis in two case subjects with FPLD with longer therapy. CONCLUSIONS Our study demonstrates the relative safety and effectiveness of GLP-1RA in patients with FPLD.

Subjects

GLP-1 receptor agonistsfamilial partial lipodystrophytype 2 diabetesweight lossglycemic controlHbA1cfasting blood glucosetriglyceridesacute pancreatitisdrug safety

Cite

APA

Foss-freitas, M. C., Imam, S., Neidert, A., DillGomes, A., Broome, D. T., Oral, & Elif (2024). The efficacy and safety of glucagon-like-peptide-1 agonists in patients with familial partial lipodystrophy. University of Michigan Library. https://doi.org/10.7302/25183

Vancouver

Foss-freitas MC, Imam S, Neidert A, DillGomes A, Broome DT, Oral, et al. The efficacy and safety of glucagon-like-peptide-1 agonists in patients with familial partial lipodystrophy. University of Michigan Library. 2024. doi:10.7302/25183

BibTeX
@article{Fossfreitas2024,
  author = {Foss-freitas, Maria Cristina and Imam, Salman and Neidert, Adam and DillGomes, Anabela and Broome, David Tyler and Oral and Elif},
  title = {The efficacy and safety of glucagon-like-peptide-1 agonists in patients with familial partial lipodystrophy},
  journal = {University of Michigan Library},
  year = {2024},
  doi = {10.7302/25183}
}
Start for free →